Financial News
Latest News about ROIV
Recent news which mentions ROIV
Roivant Sciences Highlights Topline Data From Atopic Dermatitis Drug In Patients As Young As 2 Years
March 15, 2023
Tickers
ROIV
From Benzinga
From InvestorPlace
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
From Benzinga
Mixed Signals On Valentine's Day: How Stocks Are Reacting To January Inflation Data
February 14, 2023
From Benzinga
Earnings Scheduled For February 13, 2023
February 13, 2023
From Benzinga
From Benzinga
From Benzinga
Why Roivant Sciences' Shares Are Up Thursday
December 01, 2022
From Motley Fool
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%
November 15, 2022
From Benzinga
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
November 15, 2022
From Benzinga
Earnings Scheduled For November 14, 2022
November 14, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 08, 2022
From Benzinga
From Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
October 06, 2022
From Benzinga
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
From Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For June 28, 2022
June 28, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
